89bio Inc Financial Flexibility Index

Latest as of June 2025: -1.23x

89bio Inc financial flexibility index. 89bio Inc (ETNB) has a Financial Flexibility Index of -1.23x as of June 2025. Free cash flow of $-100.42 Million (operating CF $-100.42 Million minus capex $0.00) represents -1% of total liabilities ($81.75 Million).

Financial Flexibility Index

-1.23x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-100.42 Million
Operating CF − Capex

Total Liabilities

$81.75 Million
USD

Capital Expenditures

$0.00
USD

Financial Flexibility Index of 89bio Inc (2018–2024)

Financial flexibility index of 89bio Inc from 2018 to 2024. Historical Financial Flexibility Index trend for 89bio Inc across 7 annual periods. Explore ETNB debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

89bio Inc Financial Flexibility Index by Year (2018–2024)

89bio Inc financial flexibility index by year from 2018 to 2024. Year-by-year free cash flow to debt coverage for 89bio Inc. For the full cash flow conversion analysis, see 89bio Inc (ETNB) cash flow conversion.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2024 -4.72x $-367.81 Million $-367.82 Million $77.90 Million ▼ -119.2%
2023 -2.15x $-129.18 Million $-129.19 Million $59.96 Million ▼ -19.5%
2022 -1.80x $-81.08 Million $-81.09 Million $44.99 Million ▲ +14.3%
2021 -2.10x $-76.72 Million $-76.78 Million $36.47 Million ▲ +63.0%
2020 -5.68x $-46.12 Million $-46.24 Million $8.11 Million ▼ -25.9%
2019 -4.51x $-25.32 Million $-25.46 Million $5.61 Million ▼ -896.1%
2018 -0.45x $-12.43 Million $-12.47 Million $27.43 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities